Seneca Biopharma, Inc. (NASDAQ: SNCA)

Rowley Law PLLC is investigating potential securities law violations by Seneca Biopharma, Inc. (NASDAQ: SNCA) and its board of directors concerning the merger of the company with Leading BioSciences, Inc. Seneca Biopharma stockholders will own approximately 26.2% of the combined company. The transaction is expected to close in the first half of 2021.

If you are a stockholder of Seneca Biopharma, Inc. and are interested in obtaining additional information regarding this investigation, please fill in the contact form on this page. You may also contact Shane Rowley, Esq. at Rowley Law PLLC, 50 Main Street Suite 1000, White Plains, NY 10606, by email at, or by telephone at 914-400-1920 or 844-400-4643 (toll-free).

Rowley Law PLLC represents shareholders nationwide in class actions and derivative lawsuits in complex corporate litigation.

Attorney Advertising. Prior results do not guarantee a similar outcome.

Request Information

The submission of this form does not create an attorney-client relationship.